Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01
Published April 10, 2019 · Recall initiated: March 15, 2019
Summary
FDA records drug Class III recall D-1069-2019, published April 10, 2019 and initiated March 15, 2019. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 500 cartons (25 vials per carton); Lot: Lot #: T78193, Exp.04/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
What to do
Voluntary: Firm initiated · Letter
Get an email if CLEOCIN PHOSPHATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLEOCIN PHOSPHATE
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide USA and Guam
- Lot
- Lot #: T78193, Exp.04/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClindamycin Injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vials, Rx only, Distributed by: Alvogen, Inc., PineApril 10, 2019
- FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial,April 10, 2019
- FDAMedtronic Pulmonary Vein Ablation Catheter(R) GOLD (PVAC GOLD) 990078 - Product Usage: The Pulmonary VeinApril 3, 2019
- FDAPaltop Fully Guided Surgical Kit- containing the 1.25mm Hex Driver For surgical and restorative applicationsApril 3, 2019
- FDAPaltop Premium Surgical Kit-containing the 1.25mm Hex Driver For surgical and restorative applicationsApril 3, 2019
- FDACleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150June 26, 2013
Questions about this recall
Was Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01 recalled?
Yes. FDA published recall D-1069-2019 on April 10, 2019. Reported hazard: Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLEOCIN PHOSPHATE.